Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

We propose a protocol that shows how to differentiate induced pluripotent stem cell-derived keratinocytes and fibroblasts and generate a 3D skin organoid, using these keratinocytes and fibroblasts. This protocol contains an additional step of generating a humanized mice model. The technique presented here will improve dermatologic research.

Abstract

The skin is the body’s largest organ and has many functions. The skin acts as a physical barrier and protector of the body and regulates bodily functions. Biomimetics is the imitation of the models, systems, and elements of nature for the purpose of solving complex human problems1. Skin biomimetics is a useful tool for in vitro disease research and in vivo regenerative medicine. Human induced pluripotent stem cells (iPSCs) have the characteristic of unlimited proliferation and the ability of differentiation to three germ layers. Human iPSCs are generated from various primary cells, such as blood cells, keratinocytes, fibroblasts, and more. Among them, cord blood mononuclear cells (CBMCs) have emerged as an alternative cell source from the perspective of allogeneic regenerative medicine. CBMCs are useful in regenerative medicine because human leukocyte antigen (HLA) typing is essential to the cell banking system. We provide a method for the differentiation of CBMC-iPSCs into keratinocytes and fibroblasts and for generation of a 3D skin organoid. CBMC-iPSC-derived keratinocytes and fibroblasts have characteristics similar to a primary cell line. The 3D skin organoids are generated by overlaying an epidermal layer onto a dermal layer. By transplanting this 3D skin organoid, a humanized mice model is generated. This study shows that a 3D human iPSC-derived skin organoid may be a novel, alternative tool for dermatologic research in vitro and in vivo.

Introduction

Skin covers the outermost surface of the body and protects internal organs. The skin has various functions, including protecting against pathogens, absorbing and storing water, regulating body temperature, and excreting body waste2. Skin grafts can be classified depending on the skin source; grafts using skin from another donor are termed allografts, and grafts using the patient’s own skin are autografts. Although an autograft is the preferred treatment due to its low rejection risk, skin biopsies are difficult to perform on patients with severe lesions or an insufficient number of skin cells. In patients with severe burns, three times th....

Protocol

All procedures involving animals were performed in accordance with the Laboratory Animals Welfare Act, the Guide for the Care and Use of Laboratory Animals, and the Guidelines and Policies for Rodent Experimentation provided by the Institutional Animal Care and Use Committee (IACUC) of the School of Medicine of The Catholic University of Korea. The study protocol was approved by the Institutional Review Board of The Catholic University of Korea (CUMC-2018-0191-01). The IACUC and the Department of Laboratory Animals (DOLA.......

Representative Results

Skin is composed, for the most part, of the epidermis and the dermis. Keratinocytes are the main cell type of the epidermis, and fibroblasts are the main cell type of the dermis. The scheme of keratinocyte differentiation is shown in Figure 1A. CBMC-iPCSc were maintained in a vitronectin-coated dish (Figure 1B). In this study, we differentiated CBMC-iPSCs into keratinocytes and fibroblasts using EB formation. We generated EBs us.......

Discussion

Human iPSCs have been suggested as a new alternative for personalized regenerative medicine17. Patient-derived personalized iPSCs reflect patient characteristics that can be used for disease modeling, drug screening, and autologous transplantation18,19. The use of patient-derived iPSCs can also overcome problems regarding primary cells, a lack of adequate cell numbers, and immune reactions5,

Acknowledgements

This work was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (H16C2177, H18C1178).

....

Materials

NameCompanyCatalog NumberComments
AdenineSigmaA2786Component of differentiation medium for fibroblast
AggreWell Medium (EB formation medium)STEMCELL05893EB formation
Anti-Fibronectin antibodyabcamab23750Fibroblast marker
Anti-KRT14 antibodyabcamab7800Keratinocyte marker
Anti-Loricrin antibodyabcamab85679Stratum corneum marker
Anti-p63 antibodyabcamab124762Keratinocyte marker
Anti-Vimentin antibodySanta cruzsc-7558Fibroblast marker
BAND AID FLEXIBLE FABRICJohnson & Johnson-Bandage
Basement membrane matrix (Matrigel)BD354277Component of differentiation medium for fibroblast
BLACK SILK sutureAILEEESK617Skin graft
CaCl2SigmaC5670Component of epithelial medium for 3D skin organoid
Collagen type IBD3542363D skin organoid
Collagen type IVSanta-cruzsc-29010Component of differentiation medium for keratinocyte
Defined keratinocyte-Serum Free MediumGibco10744-019Component of differentiation medium for keratinocyte
DMEM, high glucoseGibco11995065Component of differentiation medium
DMEM/F12 MediumGibco11330-032Component of differentiation medium
Essential 8 mediumGibcoA1517001iPSC medium
FBS, QualifiedCorning35-015-CVComponent of differentiation medium for fibroblast and keratinocyte
Glutamax Supplement Gibco35050061Component of differentiation medium for fibroblast
InsulinInvtrogen12585-014Component of differentiation medium for fibroblast and keratinocyte
Iris standard curved scissorProfessionalPC-02.10Surgical instrument
Keratinocyte Serum Free MediumGibco17005-042Component of differentiation medium for keratinocyte
L-ascorbic acid 2-phosphata sesquimagnesium salt hydrateSigmaA8960Component of differentiation medium for keratinocyte
MEM Non-Essential Amino AcidGibco1140050Component of differentiation medium for fibroblast
Meriam Forceps Thumb 16 cmHIROSEHC 2265-1Surgical instrument
NOD.CB17-Prkdc SCID/JThe Jackson Laboratory001303Mice strain for skin graft
Petri dish 90 mmHyundai MicroH10090Plastic ware
Recombinant Human BMP-4R&D314-BPComponent of differentiation medium for keratinocyte
Recombinant human EGF proteinR&D236-EGComponent of differentiation medium for keratinocyte
Retinoic acidSigmaR2625Component of differentiation medium for keratinocyte
T/C Petridish 100 mm, 240/bxTPP93100Plastic ware
TransferrinSigmaT3705Component of epithelial medium for 3D skin organoid
Transwell-COL collagen-coated membrane inserts CorningCLS3492Plastic ware for 3D skin organoid 
VitronectinLife technologiesA14700iPSC culture
Y-27632 Dihydrochloridepeprotech1293823iPSC culture

References

  1. Vincent, J. F., Bogatyreva, O. A., Bogatyrev, N. R., Bowyer, A., Pahl, A. K. Biomimetics: its practice and theory. Journal of The Royal Society Interface. 3 (9), 471-482 (2006).
  2. Madison, K. C. Barrier function of the skin: "la raison d'etre" of the e....

Explore More Articles

3D Skin OrganoidCord Blood derived Induced Pluripotent Stem CellsCBMC iPSCsKeratinocyte DifferentiationFibroblastsEmbryonic Body FormationBone Morphogenetic Protein 4Rho associated Kinase InhibitorRegenerative MedicineVitronectinEDTAE8 MediumKDM1 Medium

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved